|
|
|
|
 |  |
| |
Title of technology: | |
Composition of agent for the prevention and treatment of Alzheimer's disease, and the method of said agent. |
| Date posted: | |
1 February, 2008 | |
Category: | |
Drug discovery, Herbal medicine / Nutraceuticals |
|
Summary | |
Composition of agent for the prevention and treatment of Alzheimer’s disease, and the method of said agent. The composition comprises of monacolins, anti-inflammation agents and anti-oxidant compounds extracted from red mold rice (RMR), and produced in various forms; pastils, capsules, powder, beverage, etc. | |
Description: | |
The invention is a composition of an agent for the prevention and treatment of Alzheimer’s disease, the composition comprising of monacolins, anti-inflammation agents and anti-oxidant compounds, produced in various forms: pastils, capsules, powder, beverage, etc., and the method of said agent.
Moreover, in a preferred embodiment of the invention, the minimum effective doses of monacolins, anti-oxidant compounds and anti-inflammation agents is at least greater than 100μg, 40μg and 10μg respectively, wherein the monacolines, anti-inflammation agents and anti-oxidant compounds have the optimum weights in the ratio of 40:2:1, enabling the composition to achieve the objectives of prevention and treatment of Alzheimer’s disease without causing noticeable side effects to patients.
The composition can be produced in various forms; pastils, capsules, powder, beverage, etc.
| |
Patent information: | |
Patent pending application no.: US 11963533 | |
Development status: | |
Pre-registration | |
Type of business
relationship sought: | |
Licensing or partnering | |
Contact: | |
Dr. Tzu-Ming Pan, Ph.D., Research |
| Email: | |
|
| Company or institute: | |
|
|
|
|
|
Taiwan Life Sciences Weekly
|
 |
|
 |
|
|
 |
 |
|
 |
|
| |
